<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01578525</url>
  </required_header>
  <id_info>
    <org_study_id>11-192</org_study_id>
    <nct_id>NCT01578525</nct_id>
  </id_info>
  <brief_title>Medication Safety of Elderly Patients in Hospital and Ambulatory Setting</brief_title>
  <official_title>Medication Safety of Elderly Patients in Hospital and Ambulatory Setting Considering the Transitions of Care for Home-cared Patients and Nursing Home Residents</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>RWTH Aachen University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Apothekerstiftung Nordrhein, Duesseldorf</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Foerderinitiative Pharmazeutische Betreuung e.V., Berlin</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>RWTH Aachen University</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether additional pharmaceutical care for elderly
      patients (home-cared patients, nursing-home residents) has a positive impact on drug-related
      readmissions.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2012</start_date>
  <completion_date type="Actual">April 2014</completion_date>
  <primary_completion_date type="Actual">April 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Drug-related readmission</measure>
    <time_frame>one year after discharge from the cooperating ward</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Adverse drug events</measure>
    <time_frame>during hospital stay on cooperating wards(continuous data collection during routine ward rounds;hence,duration of data collection is dependent on individual hospital stay of each patient, up to 1 year) and 1 year after discharge from the cooperating ward</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of prescribed potentially inappropriate medication (PRISCUS-criteria)</measure>
    <time_frame>during hospital stay on cooperating wards(continuous data collection during routine ward rounds;hence,duration of data collection is dependent on individual hospital stay of each patient, up to 1 year) and 1 year after discharge from the cooperating ward</time_frame>
    <description>The PRISCUS list was developed in 2010 for the German market. Potentially inappropriate medications were judged as inappropriate by an expert panel using the Delphi technique. [Holt et al., Dtsch Arztebl 2010]</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>time to readmission</measure>
    <time_frame>one year after discharge from the cooperating ward</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of accepted recommendations in the intervention group</measure>
    <time_frame>during hospital stay on cooperating wards (continuous data collection during routine ward rounds; hence, duration of data collection is dependent on individual hospital stay of each patient, up to one year) in the intervention group</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>time for intervention</measure>
    <time_frame>during hospital stay on cooperating wards (continuous data collection during routine ward rounds; hence, duration of data collection is dependent on individual hospital stay of each patient, up to one year) in the intervention group</time_frame>
    <description>time recording for pharmaceutical care service</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>drug-related problem</measure>
    <time_frame>during hospital stay on cooperating wards (continuous data collection during routine ward rounds; hence, duration of data collection is dependent on individual hospital stay of each patient, up to one year) in the intervention group</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>number of changes in medication after discharge</measure>
    <time_frame>one year</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">61</enrollment>
  <condition>Elderly</condition>
  <condition>Pharmaceutical Care</condition>
  <condition>Hospital Readmission</condition>
  <condition>Health Services for the Aged</condition>
  <condition>Medication Safety</condition>
  <arm_group>
    <arm_group_label>standard care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Standard care (by German definition), traditional care by physician and nurse on the ward</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intensified standard care</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Intensified standard care: traditional care by physician and nurse, additional pharmaceutical care by a pharmacist during hospitalization</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Pharmaceutical Care Service</intervention_name>
    <description>Checking medication under safety considerations (medication at admission, hospitalization, discharge); recommendations for potentially inappropriate medication (PRISCUS-criteria),</description>
    <arm_group_label>Intensified standard care</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patient 65 years old or older

          -  patient admitted to one of the project wards

          -  minimum hospitalization: 3 days

          -  written informed consent (patient or the legal representative)

          -  current medication of the patient at hospitalization

        Exclusion Criteria:

          -  patients included in this study previously
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Albrecht Eisert, Dr. rer. nat.</last_name>
    <role>Study Director</role>
    <affiliation>University Hospital Aachen, Hospital Pharmacy, Steinbergweg 20, 52074 Aachen, Germany</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Axel Heidenreich, Prof. Dr. med.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Aachen, Department of Urology, Pauwelsstr. 30, 50274 Aachen, Germany</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Joerg B Schulz, Prof. Dr. med.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Aachen, Department of Neurology, Pauwelsstr. 30, 52074 Aachen, Germany</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Christian Trautwein, Prof. Dr. med.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Aachen, Internal Medicine III (Gastroenterology and Metabolic Disorders), Pauwelsstr. 30, 52074 Aachen, Germany</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ulrich Jaehde, Prof. Dr. rer. nat.</last_name>
    <role>Study Chair</role>
    <affiliation>University of Bonn, Pharmaceutical Institute, Clinical Pharmacy, An der Immenburg 4, 53121 Bonn, Germany</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Rebekka Heumueller</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Aachen, Hospital Pharmacy, Steinbergweg 20, 52074 Aachen, Germany</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Nicolaus Marx, Prof. Dr. med.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Aachen,Internal Medicine I (Cardiology, Pneumology, Angiology and Internal Intensive Medicine)</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital Aachen</name>
      <address>
        <city>Aachen</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>May 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 13, 2012</study_first_submitted>
  <study_first_submitted_qc>April 13, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 17, 2012</study_first_posted>
  <last_update_submitted>October 29, 2015</last_update_submitted>
  <last_update_submitted_qc>October 29, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 30, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>medication safety</keyword>
  <keyword>elderly</keyword>
  <keyword>pharmaceutical care</keyword>
  <keyword>hospital readmission</keyword>
  <keyword>drug-related readmission</keyword>
  <keyword>Health Services for the Aged</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

